These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 26630683
1. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry. Yaman B, Kandiloğlu G, Akalin T. Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683 [Abstract] [Full Text] [Related]
2. BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods. O'Brien O, Lyons T, Murphy S, Feeley L, Power D, Heffron CCBB. J Clin Pathol; 2017 Nov; 70(11):935-940. PubMed ID: 28424234 [Abstract] [Full Text] [Related]
3. Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes. Jurkowska M, Gos A, Ptaszyński K, Michej W, Tysarowski A, Zub R, Siedlecki JA, Rutkowski P. Int J Clin Exp Pathol; 2015 Nov; 8(7):8487-93. PubMed ID: 26339422 [Abstract] [Full Text] [Related]
4. A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan. Huang WK, Kuo TT, Wu CE, Cheng HY, Hsieh CH, Hsieh JJ, Shen YC, Hou MM, Hsu T, Chang JW. Asia Pac J Clin Oncol; 2016 Dec; 12(4):403-408. PubMed ID: 27488807 [Abstract] [Full Text] [Related]
5. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions. Busam KJ, Hedvat C, Pulitzer M, von Deimling A, Jungbluth AA. Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290 [Abstract] [Full Text] [Related]
6. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia. Bezić J, Tomić I, Pavić M. Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192 [Abstract] [Full Text] [Related]
7. Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma. Sener E, Yildirim P, Tan A, Gokoz O, Tezel GG. Pathol Res Pract; 2017 May; 213(5):522-530. PubMed ID: 28216139 [Abstract] [Full Text] [Related]
8. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas. Uguen A, Talagas M, Costa S, Samaison L, Paule L, Alavi Z, De Braekeleer M, Le Marechal C, Marcorelles P. Diagn Pathol; 2015 Jul 25; 10():121. PubMed ID: 26204954 [Abstract] [Full Text] [Related]
9. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT. Hum Pathol; 2015 Jan 25; 46(1):113-9. PubMed ID: 25456393 [Abstract] [Full Text] [Related]
12. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA. Am J Surg Pathol; 2013 Jan 25; 37(1):61-5. PubMed ID: 23026937 [Abstract] [Full Text] [Related]
13. Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays. Qu K, Pan Q, Zhang X, Rodriguez L, Zhang K, Li H, Ho A, Sanders H, Sferruzza A, Cheng SM, Nguyen D, Jones D, Waldman F. J Mol Diagn; 2013 Nov 25; 15(6):790-5. PubMed ID: 23994118 [Abstract] [Full Text] [Related]
14. Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma. Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, Schneider-Stock R, Lyubchenko L, Shamanin VA. Melanoma Res; 2014 Aug 25; 24(4):322-31. PubMed ID: 24922189 [Abstract] [Full Text] [Related]
15. BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? Ponti G, Tomasi A, Maiorana A, Ruini C, Maccaferri M, Cesinaro AM, Depenni R, Manni P, Gelsomino F, Giusti F, Garagnani L, Pellacani G. Appl Immunohistochem Mol Morphol; 2016 Jan 25; 24(1):30-4. PubMed ID: 26633701 [Abstract] [Full Text] [Related]
16. BRAF V600 Mutational Status in Melanoma Correlates with Cytologic Features in Fine-Needle Aspirate Specimens. Lee PJ, Dennis K, Madan R, Fan F. Acta Cytol; 2019 Jan 25; 63(1):10-16. PubMed ID: 30396186 [Abstract] [Full Text] [Related]
17. Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry. Bruno W, Martinuzzi C, Andreotti V, Pastorino L, Spagnolo F, Dalmasso B, Cabiddu F, Gualco M, Ballestrero A, Bianchi-Scarrà G, Queirolo P, Grillo F, Mastracci L, Ghiorzo P, Italian Melanoma Intergroup (IMI). Oncotarget; 2017 Jan 31; 8(5):8069-8082. PubMed ID: 28039443 [Abstract] [Full Text] [Related]
18. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma. Satzger I, Marks L, Kerick M, Klages S, Berking C, Herbst R, Völker B, Schacht V, Timmermann B, Gutzmer R. Oncotarget; 2015 Nov 10; 6(35):37895-905. PubMed ID: 26498143 [Abstract] [Full Text] [Related]